Company Filing History:
Years Active: 2018
Title: Innovations of Markus Riessland in Neurocalcin Delta Inhibition
Introduction
Markus Riessland is a notable inventor based in Kö'ln, Germany. He has made significant contributions to the field of neuroscience through his innovative research and patents. His work primarily focuses on the therapeutic applications of neurocalcin delta inhibitors.
Latest Patents
Riessland holds a patent for "Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof." This invention relates to an inhibitor of neurocalcin delta (NCALD) for use in treating or preventing disorders associated with pathological calcium homeostasis. The patent also discusses the use of NCALD inhibitors for inducing axon proliferation in vitro and methods for differentiating and maturing neuronal stem cells (NSCs). Additionally, it addresses the restoration of impaired endocytosis due to disturbed calcium homeostasis in synaptic terminals, which is essential for the development, maturation, and maintenance of synapses and neuromuscular junctions (NMJs).
Career Highlights
Riessland is affiliated with Universität zu Köln, where he conducts his research and develops his inventions. His work has garnered attention for its potential impact on treating neurological disorders and enhancing our understanding of calcium signaling in neurons.
Collaborations
One of his notable collaborators is Brunhilde Wirth, with whom he has worked on various projects related to neurocalcin delta and its implications in neuroscience.
Conclusion
Markus Riessland's innovative work in neurocalcin delta inhibition represents a significant advancement in the field of neuroscience. His contributions have the potential to lead to new therapeutic strategies for neurological disorders.